Cytogen in prostate cancer awareness campaign:
This article was originally published in Clinica
Cytogen, which develops imaging agents and radioactive seed implants for the diagnosis and treatment of prostate cancer, is launching the second "screen, stage and support" campaign aimed at increasing prostate cancer awareness. The Princeton, New Jersey-based company is participating in a special event at the Nasdaq Market Open, together with representatives from the American Cancer Society. Around one in six men will develop prostate cancer, which is the second leading cause of cancer death among men in the US.
You may also be interested in...
Operation Warp Speed will hold back initial shipments to ensure two-dose regimens can be completed; 15 December is ‘chalk’ target date for emergency authorization of Pfizer vaccine, OWS’ Gustave Perna says, calling it only a projection that does not impinge on FDA authority. Sending only half shipments also eases burden on cold shortage capacity at state and local level, he says.
CMS acknowledges stakeholders may need more details about the plan before it is finalized and a delay will give the agency more time to ‘consider the issue.’
Private Company Edition: Venture capital financings didn’t take a break during Thanksgiving week. In addition to the $800m Resilience raised to fund manufacturing services, SomaLogic closed a $121m series A round to fund its proteomic tools for drug discovery and diagnostics development.